Market Forecast By Product (Consumables & Reagents, Instruments, Software & Services) and Competitive Landscape
Product Code: ETC10152999 | Publication Date: Jan 2025 | Updated Date: Jan 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 58 | No. of Figures: 10 | No. of Tables: 2 | |
Taiwan Conventional PCR Market Report thoroughly covers the market by Product. Taiwan Conventional PCR Market Outlook report provides an unbiased and detailed analysis of the ongoing Taiwan Conventional PCR Market trends, opportunities/high growth areas, and market drivers. This would help stakeholders devise and align their market strategies according to the current and future market dynamics.
The Taiwan Conventional PCR market has experienced notable growth, driven by a robust healthcare sector and advancements in the biomedical industry. Supported by initiatives such as the Biomedical Industry Innovation Program (BIIP) under the 5+2 Innovative Industries Plan, the biomedical sector achieved $9.9 billion in revenue in 2023, marking 5% YoY growth. Backed by the Development of Biotechnology Act, demand for PCR technology has surged in genetic testing, diagnostics, and pharmaceutical research. Additionally, Taiwan’s efficient National Health Insurance (NHI), covering 99.9% of the population, along with $9.1 million investment in telemedicine in 2023, has further reinforced the country’s healthcare system.
According to 6Wresearch, Taiwan Conventional PCR Market is projected to grow at a CAGR of 2.9% from 2024-2030F. The ongoing market expansion is projected to continue, driven by the rising prevalence of infectious diseases, with notifiable communicable disease cases reaching 84,815 in 2023 and expected to rise further. This growth is also fueled by Taiwan’s aging population, set to transition into a “super-aged society” by 2025, which underscores the increasing demand for diagnostic tools to enable timely disease detection and continuous monitoring. The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) has also played a vital role, by attracting over $1.5 billion in annual investments.
Key strategic collaborations, such as the 2023 Taiwan-US Cancer Moonshot Project and ASUS-Roche partnerships, alongside Taiwan's goal of developing a trillion-NT-dollar biomedical industry by 2025, are significantly contributing to the market expansion. Furthermore, government initiatives, including the Healthy Taiwan Initiative, Health for All Ages 2030, and the National Development Council’s focusing on precision healthcare, are driving demand for PCR testing through programs like TPHI and TPMI. These factors are set to accelerate the adoption of PCR technology, making it indispensable for precision medicine and diagnostics, and fuelled the Conventional PCR market growth in Taiwan.
Software & Services in the Taiwan PCR market is expected to experience the highest growth in coming years due to increasing demand for advanced data analysis, real-time monitoring, and workflow integration in PCR applications. With rising complexity in PCR processes, the need for specialized software for data management, assay design, and cloud-based solutions would drive innovation, leading to significant growth in this segment.
The report provides a detailed analysis of the following market segments:
1. Executive Summary |
2. Introduction |
2.1. Report Description |
2.2. Key Highlights of the Report |
2.3. Market Scope & Segmentation |
2.4. Research Methodology |
2.5. Assumptions |
3. Taiwan Conventional PCR Market Overview |
3.1. Taiwan Conventional PCR Market Revenues, 2020-2030F |
3.2. Taiwan Conventional PCR Market – Industry Life Cycle |
3.3. Taiwan Conventional PCR Market – Porter’s Five Forces |
4. Taiwan Conventional PCR Market Dynamics |
4.1. Impact Analysis |
4.2. Market Drivers |
4.3. Market Restraints |
5. Taiwan Conventional PCR Market Trends & Evolution |
6. Taiwan Conventional PCR Market Overview, By Product |
6.1. Taiwan Conventional PCR Market Revenues and Revenue Share, By Product, 2023 & 2030F |
6.1.1 Taiwan Conventional PCR Market Revenues, By Consumables & Reagents, 2020-2030F |
6.1.2 Taiwan Conventional PCR Market Revenues, By Instruments, 2020-2030F |
6.1.3 Taiwan Conventional PCR Market Revenues, By Software & Services, 2020-2030F |
7. Taiwan Conventional PCR Market Key Performance Indicators |
8. Taiwan Conventional PCR Market Opportunity Assessment |
8.1 Taiwan Conventional PCR Market Opportunity Assessment, By Product, 2030F |
9. Taiwan Conventional PCR Market Competitive Landscape |
9.1 Taiwan Conventional PCR Market Revenue Ranking, By Top 3 Companies (2023) |
9.2 Taiwan Conventional PCR Market Competitive Benchmarking, By Technical Parameters |
9.3 Taiwan Conventional PCR Market Competitive Benchmarking, By Operating Parameters |
10. Company Profiles |
11. Key Strategic Recommendations |
12. Disclaimer |
List of figures |
1. Taiwan Conventional PCR Market Revenues, 2020-2030F ($ Million) |
2. Taiwan Biomedical Sectors by Revenue (100 million $) (2022-23) |
3. Taiwan Biomedical Industry Revenue (billion $) (2020-23) |
4. Taiwan Confirmed Cases of Diseases (Indigenous & Imported), 2024 |
5. Taiwan Elderly Population Medium-Variant Projects (10,000 person) |
6. Taiwan Conventional PCR Market Revenue Share, By Product, 2023 & 2030F |
7. Taiwan Biotechnology Industry by Sector Revenue ($ Billion) |
8. Taiwan’s National Health Expenditure as a Percentage of GDP 2018-2022 |
9. Taiwan Conventional PCR Market Opportunity Assessment, By Product, 2030F |
10. Taiwan Conventional PCR Market Revenue Ranking, By Companies, 2023 |
List of tables |
1. Taiwan Conventional PCR Market Revenues, By Product, 2020-2030F ($ Million) |
2. Status of medical institutions in Taiwan, 2022-2023 |